<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30078237</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0578-1310</ISSN><JournalIssue CitedMedium="Print"><Volume>56</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Aug</Month><Day>02</Day></PubDate></JournalIssue><Title>Zhonghua er ke za zhi = Chinese journal of pediatrics</Title><ISOAbbreviation>Zhonghua Er Ke Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Pathogen spectrum in enteroviral infections among children in Beijing from 2010 to 2016].</ArticleTitle><Pagination><StartPage>575</StartPage><EndPage>581</EndPage><MedlinePgn>575-581</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.issn.0578-1310.2018.08.004</ELocationID><Abstract><AbstractText><b>Objective:</b> To understand the epidemiological and etiological characteristics of enterovirus (EV)-associated diseases among children in Beijing from 2010 to 2016. <b>Methods:</b> This was a repeated cross-sectional study. The throat swabs were collected from children with probable EV-associated diseases at the Children' s Hospital Affiliated to Capital Institute of Pediatrics from 2010 to 2016. The samples were sent for pan-EV, enterovirus 71 (EV-A71) and coxsackievirus A16 (CV-A16) detection by real-time fluorescence reverse transcription polymerase chain reaction (RT-PCR) . The viral types of non-EV-A71 and non-CV-A16 EV-positive samples were identified using modified RT-PCR and sequencing with CV-A6, EV-A/B group and 5 'UTR universal primers. The constituent ratios of the prevalence of different EV types in different age and gender groups were compared. <b>Results:</b> Of the 2 703 throat swabs, 1 992 (73.7%) samples were positive for EV, including EV-A71 (19.1%, 516/2 703), CV-A16 (24.3%, 658/2 703), CV-A6 (22.2%, 600/2 703), CV-A10 (4.5%, 122/2 703) and other types of EV (3.5%, 95/2 703). There was 1 case of EV-A71 and CV-A16 co-infection. The positive detection rate of EV-A group (excluding EV-A71, CV-A16, CV-A6 and CV-A10) increased from 11.3% (7/62) to 95.2% (59/62) after using the modified VP1-specific primers and PCR amplification conditions. During the period between 2010 and 2012, CV-A16 and EV-A71 predominated in EV-positive samples. However, CV-A6 accounted for 60.7% (68/112) in 2013, much higher than CV-A16 (23.2%, 26/112) and EV-A71 (12.5%, 14/112). In 2014, EVs were mainly of CV-A16 and EV-A71, but CV-A6 was the predominant type in 2015 (68.2%, 232/340) and in 2016 (38.6%, 151/391). The epidemic season of EVs was mostly from April to August, but CV-A6 showed a small epidemic peak from October to November. The male-to-female ratio of EV-positive patients was 1.50&#x2236;1, and EV-associated diseases mostly occurred in children under 5 years of age. Younger children were more susceptible to CV-A6 than to EV-A71 and CV-A16. <b>Conclusions:</b> From 2010 to 2016, there was a significant change in the spectrum of EVs in children with EV-associated diseases in Beijing. Since 2013, non-EV-A71 and non-CV-A16 increased, and CV-A6 gradually became one of the major pathogens of EV-associated diseases. The modified PCR primers and amplification conditions can effectively improve the reliability of test results.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>F Y</ForeName><Initials>FY</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Beijing Key Laboratory of Etiology of Viral Diseases in Children, Capital Institute of Pediatrics-Peking University Teaching Hospital, Beijing 100020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>R N</ForeName><Initials>RN</Initials></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Q W</ForeName><Initials>QW</Initials></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>L P</ForeName><Initials>LP</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>L Y</ForeName><Initials>LY</Initials></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author></AuthorList><Language>chi</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z111107056811041</GrantID><Agency>Beijing Municipal Science &amp; Technology Commission</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Er Ke Za Zhi</MedlineTA><NlmUniqueID>0417427</NlmUniqueID><ISSNLinking>0578-1310</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000068476" MajorTopicYN="N" Type="Geographic">Beijing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>&#x76ee;&#x7684;&#xff1a;</b> &#x5206;&#x6790;&#x5317;&#x4eac;&#x5730;&#x533a;2010&#x81f3;2016&#x5e74;&#x5f15;&#x8d77;&#x513f;&#x7ae5;&#x80a0;&#x9053;&#x75c5;&#x6bd2;&#xff08;EV&#xff09;&#x76f8;&#x5173;&#x75be;&#x75c5;&#x7684;&#x75c5;&#x539f;&#x8c31;&#x53d8;&#x5316;&#x53ca;&#x5176;&#x5404;&#x578b;&#x522b;&#x7684;&#x6d41;&#x884c;&#x8d8b;&#x52bf;&#x3002; <b>&#x65b9;&#x6cd5;&#xff1a;</b> &#x91c7;&#x7528;&#x91cd;&#x590d;&#x6a2a;&#x65ad;&#x9762;&#x7814;&#x7a76;&#x65b9;&#x6cd5;&#xff0c;&#x5bf9;2010&#x2014;2016&#x5e74;&#x6536;&#x96c6;&#x7684;&#x9996;&#x90fd;&#x513f;&#x79d1;&#x7814;&#x7a76;&#x6240;&#x9644;&#x5c5e;&#x513f;&#x7ae5;&#x533b;&#x9662;&#x611f;&#x67d3;&#x79d1;&#x95e8;&#x8bca;&#x7591;&#x4f3c;EV&#x76f8;&#x5173;&#x75be;&#x75c5;&#x60a3;&#x513f;&#x7684;&#x53e3;&#x54bd;&#x62ed;&#x5b50;&#x6807;&#x672c;&#x8fdb;&#x884c;EV&#x7b5b;&#x67e5;&#x3002;&#x4f7f;&#x7528;&#x5b9e;&#x65f6;&#x8367;&#x5149;&#x53cd;&#x8f6c;&#x5f55;&#xff08;RT&#xff09;PCR&#x53cd;&#x5e94;&#x68c0;&#x6d4b;EV&#x3001;&#x80a0;&#x9053;&#x75c5;&#x6bd2;71&#x578b;&#xff08;EV-A71&#xff09;&#x548c;&#x67ef;&#x8428;&#x5947;&#x75c5;&#x6bd2;A&#x7ec4;16&#x578b;&#xff08;CV-A16&#xff09;&#x3002;&#x7ecf;&#x81ea;&#x884c;&#x8bbe;&#x8ba1;&#x5f15;&#x7269;&#x3001;&#x6539;&#x8fdb;&#x5f15;&#x7269;&#x53ca;PCR&#x6269;&#x589e;&#x6761;&#x4ef6;&#xff0c;&#x901a;&#x8fc7;RT-PCR&#x65b9;&#x6cd5;&#x5bf9;EV&#x9633;&#x6027;&#x800c;EV-A71&#x548c;CV-A16&#x9634;&#x6027;&#x6807;&#x672c;&#x4f9d;&#x6b21;&#x7528;CV-A6&#x3001;EV-A&#x548c;B&#x7ec4;&#x7279;&#x5f02;&#x6027;&#x5f15;&#x7269;&#x4ee5;&#x53ca;5'UTR&#x901a;&#x7528;&#x5f15;&#x7269;&#x8fdb;&#x884c;&#x6269;&#x589e;&#x3001;&#x6d4b;&#x5e8f;&#x4ee5;&#x786e;&#x5b9a;&#x578b;&#x522b;&#x3002;&#x901a;&#x8fc7;&#x8ba1;&#x7b97;&#x6784;&#x6210;&#x6bd4;&#x7684;&#x65b9;&#x5f0f;&#x5206;&#x6790;&#x4e0d;&#x540c;EV&#x578b;&#x522b;&#x7684;&#x6d41;&#x884c;&#x7279;&#x70b9;&#x4ee5;&#x53ca;&#x5728;&#x4e0d;&#x540c;&#x5e74;&#x9f84;&#x7ec4;&#x7684;&#x5206;&#x5e03;&#x60c5;&#x51b5;&#xff0c;&#x4f7f;&#x7528;&#x3c7;(2)&#x68c0;&#x9a8c;&#x5bf9;&#x60a3;&#x513f;&#x6027;&#x522b;&#x7684;&#x5dee;&#x5f02;&#x8fdb;&#x884c;&#x7edf;&#x8ba1;&#x5b66;&#x5206;&#x6790;&#x3002; <b>&#x7ed3;&#x679c;&#xff1a;</b> &#x6536;&#x96c6;&#x7684;2 703&#x4efd;&#x53e3;&#x54bd;&#x62ed;&#x5b50;&#x6807;&#x672c;&#x4e2d;EV&#x9633;&#x6027;&#x6807;&#x672c;&#x5171;1 992&#x4f8b;&#xff0c;&#x603b;&#x9633;&#x6027;&#x7387;&#x4e3a;73.7%&#xff0c;&#x5176;&#x4e2d;EV-A71&#x7684;&#x9633;&#x6027;&#x7387;&#x4e3a;19.1%&#xff08;516&#x4efd;&#xff09;&#xff0c;CV-A16&#x4e3a;24.3%&#xff08;658&#x4efd;&#xff09;&#xff0c;CV-A6&#x4e3a;22.2%&#xff08;600&#x4efd;&#xff09;&#xff0c;CV-A10&#x4e3a;4.5%&#xff08;122&#x4efd;&#xff09;&#xff0c;&#x5176;&#x4ed6;&#x578b;&#x522b;EV&#x4e3a;3.5%&#xff08;95&#x4efd;&#xff09;&#xff0c;&#x8fd8;&#x6709;1&#x4efd;&#x6807;&#x672c;&#x4e3a;EV-A71&#x548c;CV-A16&#x540c;&#x65f6;&#x9633;&#x6027;&#xff0c;&#x63d0;&#x793a;&#x5171;&#x611f;&#x67d3;&#x3002;&#x901a;&#x8fc7;&#x6539;&#x8fdb;EV-A&#x7ec4;VP1&#x7279;&#x5f02;&#x6027;&#x5f15;&#x7269;&#x548c;PCR&#x6269;&#x589e;&#x6761;&#x4ef6;&#x540e;&#xff0c;EV-A&#x7ec4;&#xff08;&#x9664;EV-A71&#x3001;CV-A16&#x3001;CV-A6&#x548c;CV-A10&#xff09;&#x9633;&#x6027;&#x68c0;&#x51fa;&#x7387;&#x7531;11.3%&#xff08;7/62&#xff09;&#x589e;&#x52a0;&#x81f3;95.2%&#xff08;59/62&#xff09;&#x3002;2010&#x2014;2012&#x5e74;&#xff0c;EV&#x9633;&#x6027;&#x6807;&#x672c;&#x4e2d;CV-A16&#x548c;EV-A71&#x6240;&#x5360;&#x6bd4;&#x4f8b;&#x6700;&#x9ad8;&#xff1b;&#x7136;&#x800c;2013&#x5e74;CV-A6&#x4ee3;&#x66ff;CV-A16&#x548c;EV-A71&#x6210;&#x4e3a;&#x4e3b;&#x5bfc;&#x75c5;&#x539f;&#xff0c;&#x6240;&#x5360;&#x6bd4;&#x4f8b;&#x8fbe;60.7%&#xff08;68/112&#xff09;&#xff0c;&#x8fdc;&#x8fdc;&#x9ad8;&#x4e8e;CV-A16&#xff08;23.2%,26/112&#xff09;&#x548c;EV-A71&#xff08;12.5%,14/112&#xff09;&#xff1b;2014&#x5e74;&#xff0c;EV&#x578b;&#x522b;&#x4ecd;&#x4ee5;CV-A16&#x548c;EV-A71&#x4e3a;&#x4e3b;&#xff1b;2015&#x548c;2016&#x5e74;&#x5747;&#x4ee5;CV-A6&#x6240;&#x5360;&#x6bd4;&#x4f8b;&#x6700;&#x9ad8;&#xff0c;&#x5206;&#x522b;&#x4e3a;68.2%&#xff08;232/340&#xff09;&#x548c;38.6%&#xff08;151/391&#xff09;&#x3002;EV&#x7684;&#x6d41;&#x884c;&#x5b63;&#x8282;&#x591a;&#x4e3a;4&#x81f3;8&#x6708;&#x4efd;&#xff0c;&#x4f46;&#x6bcf;&#x5e74;&#x7a0d;&#x6709;&#x4e0d;&#x540c;&#xff0c;CV-A6&#x5728;10&#x548c;11&#x6708;&#x4efd;&#x4f1a;&#x51fa;&#x73b0;&#x5c0f;&#x7684;&#x6d41;&#x884c;&#x9ad8;&#x5cf0;&#x3002;EV&#x9633;&#x6027;&#x6807;&#x672c;&#x4e2d;&#x7684;&#x7537;&#x5973;&#x6027;&#x522b;&#x6bd4;&#x4e3a;1.50&#x2236;1&#xff0c;&#x4ee5;5&#x5c81;&#x4ee5;&#x4e0b;&#x513f;&#x7ae5;&#x591a;&#x89c1;&#x3002;&#x4e0e;EV-A71&#x548c;CV-A16&#x76f8;&#x6bd4;&#xff0c;CV-A6&#x66f4;&#x6613;&#x611f;&#x67d3;&#x5e74;&#x9f84;&#x504f;&#x5c0f;&#x7684;&#x513f;&#x7ae5;&#x3002; <b>&#x7ed3;&#x8bba;&#xff1a;</b> 2010&#x2014;2016&#x5e74;&#x5317;&#x4eac;&#x5730;&#x533a;&#x513f;&#x7ae5;&#x4e2d;EV&#x611f;&#x67d3;&#x7684;&#x75c5;&#x4f8b;&#x4e2d;EV&#x75c5;&#x539f;&#x8c31;&#x53d1;&#x751f;&#x4e86;&#x660e;&#x663e;&#x53d8;&#x5316;&#xff0c;&#x81ea;2013&#x5e74;&#x4ee5;&#x6765;&#xff0c;&#x975e;EV-A71&#x548c;CV-A16&#x7684;&#x75c5;&#x539f;&#x589e;&#x591a;&#xff0c;CV-A6&#x9010;&#x6e10;&#x6210;&#x4e3a;EV&#x611f;&#x67d3;&#x6027;&#x75be;&#x75c5;&#x7684;&#x4e3b;&#x8981;&#x75c5;&#x539f;&#x4f53;&#x4e4b;&#x4e00;&#x3002;&#x5bf9;PCR&#x5f15;&#x7269;&#x548c;&#x6269;&#x589e;&#x6761;&#x4ef6;&#x7684;&#x6539;&#x8fdb;&#x53ef;&#x4ee5;&#x6709;&#x6548;&#x5730;&#x63d0;&#x9ad8;&#x68c0;&#x6d4b;&#x7ed3;&#x679c;&#x7684;&#x53ef;&#x9760;&#x7a0b;&#x5ea6;&#x3002;.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus infections</Keyword><Keyword MajorTopicYN="N">Epidemiological study characteristics as topic</Keyword><Keyword MajorTopicYN="N">Pathogen spectrum</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30078237</ArticleId><ArticleId IdType="doi">10.3760/cma.j.issn.0578-1310.2018.08.004</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>